Mariel Sullivan, MD

University of Vermont Medical Center
Burlington, Vermont, United States

Disclosure information not submitted.

Presentation(s):

• SAT-787 - Romosozumab vs Alendronate and Cardiovascular/Cerebrovascular Events in Osteoporosis: 1-, 3-, 5-Year and Ever-before-Treatment Outcomes in 1,184,957 Patients with and without Prior CVD/Stroke (Trinetx Cohort)

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT